General Information of Drug (ID: DMBIYNH)

Drug Name
ETI-204 Drug Info
Indication
Disease Entry ICD 11 Status REF
Anthrax 1B97 Approved [1]
Cross-matching ID
TTD Drug ID
DMBIYNH

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AIGIV DMJVGIH Diabetic neuropathy 8C0Z Phase 1/2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacillus anthracis Protective antigen (Anthrax PA) TTRLPUB PAG_BACAN Not Available [2]

References

1 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.
2 Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax. Antimicrob Agents Chemother. 2015 Apr;59(4):2206-14.
3 Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax. Antimicrob Agents Chemother. 2013 Nov;57(11):5684-92.